RxDoctor Payments DataLook up a doctor →

John Davies, MD

Ophthalmology · Minneapolis, MNNPI 1811904212

Payments from drug & device makers

$1,254,334in general payments, 2019–2025

Across 98 payments — averaging $12,799 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ocular Therapeutix, Inc.$810K
  • Eyepoint US, Inc.$376K
  • Janssen Research & Development, LLC$68K
  • Dutch Ophthalmic, USA$146

General payments by program year

23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,254,334 in reported general payments places this provider in the 95th percentile of 330 ophthalmology providers in Minnesota.

See all ophthalmology providers in Minnesota

Medicare billing

Part B allowed, 2024
$6,030,102
Medicare patients
1,079
Services billed
53,032

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other ophthalmology in Minneapolis

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →